Advertisement
Xeris Biopharma Holdings, Inc. (XERS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
As of 03:19PM EST. Market open.
| Previous Close | 2.9200 |
| Open | 2.9100 |
| Bid | 2.9000 x 100 |
| Ask | 2.9100 x 100 |
| Day's Range | 2.8200 - 2.9300 |
| 52 Week Range | 1.6900 - 3.6400 |
| Volume | |
| Avg. Volume | 1,618,329 |
| Market Cap | 433.08M |
| Beta (5Y Monthly) | 1.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4300 |
| Earnings Date | Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.77 |
Simply Wall St.Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long
With the business potentially at an important milestone, we thought we'd take a closer look at Xeris Biopharma...
GuruFocus.comXeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
Xeris Biopharma Holdings Inc (XERS) reports a robust quarter with significant revenue increases and strategic pipeline progress, despite facing competitive and operational challenges.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.